Clinical trial
The Effects of Ripasudil in Patients With Fuchs Endothelial Corneal Dystrophy Undergoing Femtosecond Laser Assisted Cataract Surgery
NCT06048380 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Ripasudil in Patients With Fuchs Endothelial Corneal Dystrophy Undergoing Femtosecond Laser Assisted Cataract Surgery
- Lead sponsor
- Singapore Eye Research Institute
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 1, 2025
- Completion date
- July 31, 2025
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.